Andrew John Partridge, EVP & Chief Commercial Officer at Turning Point Therapeutics, Inc. (TPTX), sold 3,738 shares at $74.90 ($280K) on 2021-07-14, disclosed to the SEC on 2021-07-15.
Open-market sale of $280k TPTX by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.90 | 1,869 | $140K | 50.0% |
| 2 | $74.90 | 1,869 | $140K | 50.0% |
| Total | $74.90 avg | 3,738 | $280K | 100% |
| Filing → |